ESR1 and breast cancer: It is well known that E2 stimulates proliferation and metastatic potential of ERα positive breast cancer cells54, and because tumor progression and resistance to chemotherapy are associated with elevated levels of SOCS355 and STAT356, it is tempting to speculate that the effects of the estrogen on tumor macrophages may be involved in E2-dependent cancer growth.